Human TSLP DNA and polypeptides
US6555520B2 · kind B2 · utility
24Cited by
0References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 9, 2001 |
| Grant date | Apr 29, 2003 |
| Priority date | — |
| Expiry date | May 9, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to purified and isolated novel TSLP polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.